Gout is one of the most common inflammatory joint diseases and presents a significant burden for many people in Australia. There are several gaps between evidence and practice that need to be addressed to improve the management of these patients.^3,4

These evidence–practice gaps stem from several factors, including updated management recommendations, limited time for clinicians to educate patients on medications, deprioritising gout compared with other coexisting conditions, and enduring myths that perpetuate the stigma surrounding gout (see figure 1).